SEC Form 4 · accession 0001574774-19-000006

BIOTELEMETRY, INC. · BEAT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Executive VP & CFO

Period of report

Jan 31, 2019

Accepted (ET)

Feb 1, 2019 · 5:35 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001574774

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jan 31, 2019	M	100	$2.80	A	80,661	D
Common Stock	Jan 31, 2019	S	100	$70.01	D	80,561	D
Common Stock	Feb 1, 2019	M	10,490	$2.80	A	91,051	D
Common Stock^F2	Feb 1, 2019	S	10,490	$70.41	D	80,561	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Options (Right to Buy)^F3	$2.80	Jan 31, 2019	M	100	D	—	Feb 21, 2022	Common Stock	100	10,490	D
Stock Options (Right to Buy)^F3	$2.80	Feb 1, 2019	M	10,490	D	—	Feb 21, 2022	Common Stock	10,490	0	D

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2018.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $70.00 to $72.12, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F3The stock options vested in four equal annual installments, which began on December 31, 2012. The options were fully exercisable as of December 31, 2015.